Objective  To understand the current situation of medical order review of Pharmacy Intravenous Admixture Services (PIVAS) in Hebei Province, analyze the existing problems, and propose suggestions to provide reference for further strengthening the quality control of medical order review of PIVAS.

Methods  From January 1, 2024 to June 30, 2024, in the form of a questionnaire survey, a cross-sectional survey was conducted on the overview, content, quality control and continuing education of pharmacists in 34 PIVAS of medical institutions in Hebei Province, and the results were statistically analyzed.

Results  In 34 PIVAS (27 in tertiary hospitals and 7 in non-tertiary hospitals), both tertiary and non-tertiary hospitals had the majority of pharmacists to review the medical orders (6.19±10.35) vs. (5.29±5.22) with a bachelor's degree and intermediate professional title (5.31±5.07) vs. (2.71±2.14). Only 11 PIVAS had full-time pharmacists to review the medical orders. A total of 30 PIVAS used the "information system + manual review" mode for prescription review, with a significantly higher number in tertiary hospitals compared to non-tertiary hospitals (P<0.001). Only 3 hospitals' PIVAS conducted full prescription reviews, all of which were tertiary hospitals. Only 5 tertiary hospitals and 2 non-tertiary hospitals had prescription review pharmacists participating in ward rounds, consultations, and discussions of critical cases, with no statistically significant difference (P﹥0.0.5).

Conclusion  The medical order review of PIVAS in Hebei Province has achieved certain results in ensuring the safety and effectiveness of infusion, but it is still necessary to enhance pharmacist service skills and information construction level, standardize the content of medical order review, strengthen the quality control of medical order review, and gradually establish a standardized operation process for medical order review.

1.国家卫生健康委. 静脉用药调配中心建设与管理指南(试行) [S]. 2021.

2.国家药品监督管理局.国家药品不良反应监测年度报告(2021年) [EB/OL]. (2022-03-30) [2024-10-01]. https://www.nmpa.gov.cn/xxgk/yjjsh/ypblfytb/20220329161925106.html.

3.石军飞, 崔鸿江, 刘娟. 等. 临床药师参与全医嘱审核并对不合理医嘱实施干预的效果分析[J]. 中国临床药学杂志, 2022, 31(8): 610-614. [Shi JF, Cui HJ, Liu J, et al. Analysis of the effect of clinical pharmacists participated in the implementation of the whole doctor's advice review and intervening in unreasonable doctor's advice[J]. Chinese Journal of Clinical Pharmacy, 2022, 31(8): 610-614.] DOI: 10.19577/j.1007-4406.2022.08.010.

4.国家卫生健康委员会办公厅, 国家中医药管理局办公室, 中央军委后勤保障部办公厅. 关于印发(医疗机构处方审核规范)的通知[Z]. 2018.

5.郭冬杰, 李朋梅, 陈文倩. 等. 重症监护患者亚胺培南治疗药物监测真实世界横断面调查[J]. 中国药学杂志, 2020, 55(8): 650-655. [Guo DJ, Li PM, Chen WQ, et al. Cross sectional survey on therapeutic drug monitoring of imipenem in critically Ill patients of the real world[J]. Chinese Pharmaceutical Journal, 2020, 55(8): 650-655.] DOI: 10.11669/cpj.2020.08.014.

6.杜雅薇, 刘维, 王干成. 等. 一项静脉用药调配中心对比分析的横断面研究[J]. 中国医院药学杂志, 2021, 41(2): 207-209. [Du YW, Liu W, Wang GC, et al. Comparative analysis of pharmacy intravenous admixture services: a cross-sectional study[J]. Chinese Journal of Hospital Pharmacy, 2021, 41(2): 207-209.] DOI: 10.13286/j.1001-5213.2021.02.15.

7.吴迪, 张明霞, 韦薇, 等. 基于甘肃省医疗机构PIVAS建设及运行现状调查的多中心横断面研究[J]. 中国医院药学杂志, 2022, 42(15): 1594-1599. [Wu D, Zhang MX, Wei W, et al. Based on the current status of PIVAS construction and operation in medical institutions in Gansu: a cross-sectional study[J]. Chinese Journal of Hospital Pharmacy, 2022, 42(15): 1594-1599.] DOI: 10.13286/j.1001-5213.2022.15.17.

8.所伟, 王悦, 陈亮. 等. 北京市属医院住院医嘱点评审核工作现状调查与分析[J]. 中国药房, 2024, 35(10): 1266-1270. [Suo  W, Wang Y, Chen L, et al. Investigation and analysis of the review and comment on inpatient medical orders in Beijing municipal hospitals[J]. China Pharmacy, 2024, 35(10): 1266-1270.] DOI: 10.6039/j.issn.1001-0408.2024.10.20.

9.董卫华, 岳媛, 马娟鹃. 等. 陕西省医疗机构静脉用药调配中心运行情况调研[J]. 中国医院药学杂志, 2019 , 39(20): 2019-2024. [Dong WH, Yue Y, Ma JJ, et al. Investigation and study on PIVAS in hospitals of Shaanxi province[J]. Chinese Journal of Hospital Pharmacy, 2019, 39(20): 2019-2024.] DOI: 10.13286/j.cnki.chinhosppharmacyj.2019.20.01.

10.杨春松, 杨亚亚, 张伶俐. 等. 我国PIVAS药(护)师科研培养现状及其影响因素的调查分析[J]. 中国药房, 2020, 31(14): 1783-1787. [Yang CS, Yang YY, Zhang LL, et al. Investigation and analysis of the status quo and influence factors for scientific research training of pharmacists (nurses) in PIVAS of China[J]. China Pharmacy, 2020, 31(14): 1783-1787.] DOI: 10.6039/j.issn.1001-0408.2020.14.21.

11.侯疏影, 王振, 史文秀. 等. 全国63家“三甲”医院静脉用药调配中心对临床药师职能需求的调研[J]. 中国药房, 2017, 28(6): 725-729. [Hong SY, Wang Z, Shi WX, et al. Investigation and study on the competence required of clinical pharmacist in PIVAS of 63 third-grade class A hospitals in China[J]. China Pharmacy, 2017, 28(6): 725-729.] DOI: 10.6039/j.issn.1001-0408.2017.06.02.

12.刘冰, 李聃. 静脉用药调配中心药师24 h全医嘱审核对合理用药及调配效率的作用[J]. 西北药学杂志, 2023, 38(5): 220-223. [Liu B, Li D. Effect of pharmacy intravenous admixture service pharmacists' 24 hours medical order review on rational drug use and dispensing efficiency[J]. Northwest Pharmaceutical Journal, 2023, 38(5): 220-223.] DOI: 10.3969/j.issn.1004-2407.2023.05.039.

13.鲁国璋, 张建中. 上海市39家医疗机构静脉用药调配中心建设及运行情况调研[J]. 上海医药, 2023, 44(15): 50-55. [Lu GZ, Zhang JZ. Investigation and study on construction and operation of PIVAS in 39 hospital of Shanghai[J]. Shanghai Medical & Pharmaceutical Journal, 2023, 44(15): 50-55.] DOI: 10.3969/j.issn.1006-1533.2023.15.013.

14.陈春燕, 单慧亭, 李东锋. 基于“审方系统+临床药师” 的全医嘱前置审核模式的探索实践[J]. 药学服务与研究, 2021, 21(4): 308-310. [Chen CY, Shan HT, Li DF. Exploration and practice of the pre-prescription review mode of medical orders based on prescription review systew plus clinical pharmacists[J]. Pharmaceutical Care and Research, 2021, 21(4): 308-310.] DOI: 10.5428/pcar2021041.

15.中华人民共和国国家卫生健康委员会. 抗肿瘤药物临床应用管理办法(试行)[S]. 2020.

16.Krens SD, Lassche G, Jansman FGA, et al. Dose recommendations for anticancer drugs in patients with renal or hepatic impairment[J]. Lancet Oncol, 2019, 20(4): e200-e207. DOI: 10.1016/S1470-2045(23)00216-4.

17.马旖旎, 史天陆. 药师处方审核工作质量的再评价[J]. 医药导报, 2019, 38(2): 252-256. [Ma YN, Shi TL. Quality reassessment of pharmacist's prescription checking[J]. Herald of Medicine, 2019, 38(2): 252-256.] DOI: 10.3870/j.iSSN.1004-0781.2019.02.025.